GeoVax Labs, Inc. (GOVX): Total Liabilities
$2.52M
As of 2025-12-31
$2.88M
As of 2026-06-30
-19.1%
3-year compound annual growth
+25.0%
5-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $2.52M | -19.0% | 2026-04-15, Balance as of period end |
| 2024-12-31 | $3.11M | n/a | 2026-04-15, Balance as of period end |
| No annual figure between 2022-12-31 and 2024-12-31. | |||
| 2022-12-31 | $4.75M | -36.1% | 2023-03-23, Balance as of period end |
| 2021-12-31 | $7.44M | +801.2% | 2023-03-23, Balance as of period end |
| 2020-12-31 | $825.0K | -59.6% | 2022-03-09, Balance as of period end |
| 2019-12-31 | $2.04M | +22.8% | 2021-03-23, Balance as of period end |
| 2018-12-31 | $1.66M | +105.2% | 2020-03-24, Balance as of period end |
| 2017-12-31 | $811.3K | n/a | 2019-03-26, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| GeoVax Labs, Inc. (GOVX) | 2025-12-31 | $2.52M | -19.0% |
| Cartesian Therapeutics, Inc. (RNAC) | 2025-12-31 | $422.65M | -4.3% |
| Upstream Bio, Inc. (UPB) | 2025-12-31 | $14.00M | +18.0% |
| Xenetic Biosciences, Inc. (XBIO) | 2025-12-31 | $968.0K | +8.2% |
| TherapeuticsMD, Inc. (TXMD) | 2025-12-31 | $10.78M | -5.9% |
| Dianthus Therapeutics, Inc. (DNTH) | 2025-12-31 | $37.52M | +74.3% |
| Lipocine Inc. (LPCN) | 2025-12-31 | $2.53M | +67.1% |
| Bio Essence Corp (BIOE) | 2025-12-31 | $2.50M | -23.2% |
| Camp4 Therapeutics Corp (CAMP) | 2025-12-31 | $70.10M | +362.3% |
Compare GOVX, RNAC, UPB, XBIO side by side · Screen every company in Pharmaceutical Preparations ↗